Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

MorphoSys and Boehringer Ingelheim collaborate on therapeutic antibodies

Feb. 27, 2003

Label for Botox widened in Europe

Feb. 27, 2003

Promising results reported for Targretin in chronic severe hand dermatitis

Feb. 25, 2003

Delay announced in European approval for Amevive

Feb. 21, 2003

Pharmacodynamics and pharmacokinetics of infliximab in psoriatic patients

Feb. 18, 2003

Serono's Raptiva marketing rights extended to Asia

Feb. 10, 2003

Novel PLA2 inhibitors discovered by Nippon Soda scientists

Feb. 10, 2003

Leo Pharma validates psoriasis target from Switch Biotech

Feb. 7, 2003

Improvement of hyperandrogenic alopecia in women after 1-year treatment with flutamide

Feb. 5, 2003

First biologic therapy for psoriasis approved by FDA

Feb. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...